Erratum: Copper in alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies (Journal of Alzheimer's Disease (2012) 30 (9981-984))

Journal of Alzheimer's Disease

Volumn 30, Issue 4, 2012, Pages 981-984

  Ventriglia, Mariacarla ^a,b   Bucossi, Serena ^a   Panetta, Valentina ^b,c   Squitti, Rosanna ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c Biostatistics Office   (Italy)

Author keywords

Alzheimer's disease; copper; meta analysis; serum

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL; ALZHEIMER DISEASE; BLOOD; CEREBROSPINAL FLUID; HUMAN; META ANALYSIS; REVIEW;

BIOLOGICAL MARKER; COPPER;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COPPER; HUMANS;

EID: 84863001200     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120244     Document Type: Erratum

References (22)

1. Mueller C, Schrag M, Crofton A, Stolte J, Muckenthaler MU, Magaki S, Kirsch W (2012) Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. J Alzheimers Dis 29, 341-350.
2. Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti R (2011) Copper in Alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 24, 175-185.
3. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini PM (2006) Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta] amyloid, and h-tau. Neurology 67, 76-82.
4. Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, Vernieri F, Rossi L, Baldassini M, Rossini PM (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64, 1040-1046.
5. Squitti R, Ventriglia M, Barbati G, Cassetta E, Ferreri F, Dal Forno G, Ramires S, Zappasodi F, Rossini PM (2007) 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114, 1589-1594.
6. Zappasodi F, Salustri C, Babiloni C, Cassetta E, Del Percio C, Ercolani M, Rossini PM, Squitti R (2008) An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease. Brain Res 1215, 183-189.
7. Molaschi M, Ponzetto M, Bertacna B, Berrino E, Ferrario E (1996) Determination of selected trace elements in patients affected by dementia. Arch Gerontol Geriatr 22(SUPPL. 1), 39-42.
8. Shore D, Henkin RI, Nelson NR, Agarwal RP, Wyatt RJ (1984) Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia. J AmGeriatr Soc 32, 892-895.
9. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer's disease. Neurology 59, 1153-1161.
10. Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM (2011) Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol 94, 296-306.
11. Agarwal R, Kushwaha SS, Tripathi CB, Singh N, Chillar N (2008) Serum copper in Alzheimer's disease and vascular dementia. Indian J Clin Biochem 23, 369-374.
12. Baum L, Chan IH, Cheung SK, Goggins WB, Mok V, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Zee BC, Cheng W, Chan MH, Szeto S, Lui V, Tsoh J, Bush AI, Lam CW, Kwok T (2010) Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals 23, 173-179.
13. Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A (2005) Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita 41, 197-203.
14. Brewer GJ, Kanzer SH, Zimmerman EA, Celmins DF, Heckman SM, Dick R (2010) Copper and ceruloplasmin abnormalities in Alzheimer's disease. Am J Alzheimers Dis Other Demen 25, 490-497.
15. Gonzalez C, Martin T, Cacho J, BrenasMT, Arroyo T, Garcia-Berrocal B, Navajo JA, Gonzalez-Buitrago JM (1999) Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur J Clin Invest 29, 637-642.
16. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282.
17. Kapaki E, Segditsa J, Zournas C, Xenos D, Papageorgiou C (1989) Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Experientia 45, 1108-1110.
18. Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm 105, 479-488.
19. Ozcankaya R, Delibas N (2002) Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: Crosssectional study. Croat Med J 43, 28-32.
20. Sedighi B, Shafa MA, Shariati M (2006) A study of serum copper and ceruloplasmin in Alzheimer's disease in Kerman, Iran. Neurology Asia 11, 107-109.
21. Sevym S, Unal O, Tamer L, Do?gu O, Ozge A (2007) Can serum levels of copper and zinc distinguish Alzheimer's patients from normal subjects? J Neurol Sci (Turkish) 24, 197-205.
22. Smorgon C, Mari E, Atti AR, Dalla Nora E, Zamboni PF, Calzoni F, Passaro A, Fellin R (2004) Trace elements and cognitive impairment: An elderly cohort study. Arch Gerontol Geriatr SUPPL. 9, 393-402.